4.4 Article

GABAA ρ receptor mechanisms in the rat amygdala and its role in the modulation of fear and anxiety

Journal

PSYCHOPHARMACOLOGY
Volume 212, Issue 4, Pages 475-484

Publisher

SPRINGER
DOI: 10.1007/s00213-010-1973-x

Keywords

Anxiety; Amygdala; GABA C receptors; GABA rho receptors; Elevated plus-maze; Corticosterone; Intercalated paracapsular islands

Funding

  1. Computing Unit of the Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico
  2. Direccion de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico [IN200508]
  3. Mexican Research Council [CONACyT 194963]

Ask authors/readers for more resources

Accumulating evidence for the presence of GABA(A) rho receptors within the amygdala which differ from other members of the GABA(A) receptor family in both subunit composition and functional properties has been recently obtained. This work was conducted to study whether GABA(A) rho receptors may have a putative role in the amygdaloid modulation of fear and anxiety. It was found that the bilateral intra-amygdaloid administration (6-240 pmol/side) of (1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid, a selective GABA(A) rho receptor antagonist, reduced dose-dependently the exploration of the open arms of the elevated plus-maze without affecting locomotion and increased the plasma levels of corticosterone. In contrast, bicuculline in the dose range used (1.8-60 pmol/side) induced seizures, but had no effects on the exploration of the maze. It is suggested that GABA(A) rho receptors may have a role in the amygdaloid modulation of fear and anxiety.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Pharmacology & Pharmacy

Editorial: Purinergic Signaling 2020: The State-of-The-Art Commented by the Members of the Italian Purine Club

Francisco Ciruela, Kjell Fuxe, Peter Illes, Henning Ulrich, Francesco Caciagli

FRONTIERS IN PHARMACOLOGY (2021)

Article Clinical Neurology

Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression

Antonio Flores-Burgess, Carmelo Millon, Belen Gago, Laura Garcia-Duran, Noelia Cantero-Garcia, Araceli Puigcerver, Jose Angel Narvaez, Kjell Fuxe, Luis Santin, Zaida Diaz-Cabiale

Summary: The study revealed that GAL(1-15) enhances the antidepressant effects of FLX in a depression animal model, potentially mediated through 5-HT1AR. This opens up the possibility of using a combination of GAL(1-15) and FLX as a novel treatment strategy for depression.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)

Editorial Material Pharmacology & Pharmacy

Molecular Integration in Adenosine Heteroreceptor Complexes Through Allosteric and De-Phosphorylation (STEP) Mechanisms and its Role in Brain Disease

Dasiel O. Borroto-Escuela, Luca Ferraro, Kjell Fuxe

FRONTIERS IN PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Intranasal Delivery of Galanin 2 and Neuropeptide Y1 Agonists Enhanced Spatial Memory Performance and Neuronal Precursor Cells Proliferation in the Dorsal Hippocampus in Rats

Dasiel O. Borroto-Escuela, Ramon Fores, Mariana Pita, Miguel A. Barbancho, Pablo Zamorano-Gonzalez, Natalia Garcia Casares, Kjell Fuxe, Manuel Narvaez

Summary: This study assesses the effects of GALR2 and NPYY1R agonists coadministration on sustained memory and hippocampal cell proliferation, suggesting the potential therapeutic benefits for dementia conditions and memory deficits.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

The Combination of Galanin (1-15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression

Noelia Cantero-Garcia, Antonio Flores-Burgess, David Ladron de Guevara-Miranda, Antonia Serrano, Laura Garcia-Duran, Araceli Puigcerver, Kjell Fuxe, Jose Angel Narvaez, Luis Javier Santin, Zaida Diaz-Cabiale, Carmelo Millon

Summary: This study analyzed the effect of GAL(1-15) on alcohol consumption and depression treatment. The combination of GAL(1-15) and ESC significantly reduced alcohol intake and enhanced ESC's reduction of reward capacity. Additionally, GAL(1-15) reversed the adverse effects of ESC in depression-related behavioral tests and forced swimming tests in rats.

BIOMEDICINES (2022)

Review Cell Biology

Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders

Miguel Perez de la Mora, Dasiel O. Borroto-Escuela, Minerva Crespo-Ramirez, Jose del Carmen Rejon-Orantes, Daniel Alejandro Palacios-Lagunas, Magda K. Martinez-Mata, Daniela Sanchez-Luna, Emiliano Tesoro-Cruz, Kjell Fuxe

Summary: Major depressive disorder (MDD) and anxiety are highly prevalent mental diseases with negative impacts on society and patients. Finding effective treatments with limited side effects is an important goal. This review focuses on the role of G-protein coupled receptors (GPCRs), such as serotonin, dopamine, galanin, and opioid heteroreceptor complexes, in regulating synaptic transmission in the limbic networks of the brain, and how understanding these mechanisms can contribute to the development of new treatments for MDD and anxiety disorders.

CELLS (2022)

Article Biochemistry & Molecular Biology

Galanin and Neuropeptide Y Interaction Enhances Proliferation of Granule Precursor Cells and Expression of Neuroprotective Factors in the Rat Hippocampus with Consequent Augmented Spatial Memory

Marina Mirchandani-Duque, Miguel A. Barbancho, Alexander Lopez-Salas, Jose Erik Alvarez-Contino, Natalia Garcia-Casares, Kjell Fuxe, Dasiel O. Borroto-Escuela, Manuel Narvaez

Summary: This study evaluated the role of neuropeptide Y and galanin in hippocampal neurogenesis and found that they improve spatial memory by promoting cell proliferation and inducing neuroprotective factors. This finding provides a potential novel therapy for neurodegenerative cognitive-affecting diseases.

BIOMEDICINES (2022)

Article Behavioral Sciences

Dominance status is associated with a variation in cannabinoid receptor 1 expression and amphetamine reward

Martin Migliaro, Rodolfo Sanchez-Zavaleta, Eva Soto-Tinoco, Alejandra E. Ruiz-Contreras, Monica Mendez-Diaz, Andrea Herrera-Solis, Miguel Perez de la Mora, Oscar E. Prospero-Garcia

Summary: This study reveals distinct differences in the rewarding effects of psychostimulants between dominant and subordinate individuals. Additionally, it demonstrates the association between the expression of CB1R and behavioral phenotypes related to social dominance.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2022)

Article Cell Biology

GALR2 and Y1R agonists intranasal infusion enhanced adult ventral hippocampal neurogenesis and antidepressant-like effects involving BDNF actions

Jose Erik Alvarez-Contino, Estela Diaz-Sanchez, Marina Mirchandani-Duque, Jose Andres Sanchez-Perez, Miguel A. Barbancho, Alexander Lopez-Salas, Natalia Garcia-Casares, Kjell Fuxe, Dasiel O. Borroto-Escuela, Manuel Narvaez

Summary: This study found that intranasal infusion of GALR2 and Y1R agonists promotes neuroblast proliferation and induces the expression of the neurotrophic factor BDNF in the ventral hippocampus, resulting in antidepressant effects. These effects may be mediated by increased formation of Y1R-GALR2 heteroreceptor complexes. These findings may provide a new approach for the development of novel therapies for major depressive disorder.

JOURNAL OF CELLULAR PHYSIOLOGY (2023)

Article Clinical Neurology

GPR55 activation prevents amphetamine-induced conditioned place preference and decrease the amphetamine-stimulated inflammatory response in the ventral hippocampus in male rats

Rodolfo Sanchez-Zavaleta, Jose Segovia, Alejandra E. Ruiz-Contreras, Andrea Herrera-Solis, Monica Mendez-Diaz, Miguel Perez De la Mora, Oscar E. Prospero-Garcia

Summary: The activation of GPR55 in the ventral hippocampus prevents the inflammatory response induced by amphetamine and the conditioned place preference. This suggests that GPR55 plays a crucial role in preventing the rewarding effects of amphetamine.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

5HT1AR-FGFR1 Heteroreceptor Complexes Differently Modulate GIRK Currents in the Dorsal Hippocampus and the Dorsal Raphe Serotonin Nucleus of Control Rats and of a Genetic Rat Model of Depression

Patrizia Ambrogini, Davide Lattanzi, Marica Pagliarini, Michael Di Palma, Stefano Sartini, Riccardo Cuppini, Kjell Fuxe, Dasiel Oscar Borroto-Escuela

Summary: This study investigates the effects of 5HT1AR-FGFR1 complex activation on hippocampal pyramidal neurons and midbrain dorsal raphe serotonergic neurons using an electrophysiological approach. The results show that in normal rats, FGFR1 agonist-induced allosteric action counteracts the ability of 5HT1AR to open GIRK channels, leading to increased neuronal firing. However, in a depression rat model, the change in 5HT1AR caused by FGFR1 does not affect the GIRK channels, except in CA2 neurons. Therefore, the reduced inhibitory ability of FGFR1 on 5HT1AR-mediated GIRK channel opening may be associated with depression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Behavioral Sciences

CB1R chronic intermittent pharmacological activation facilitates amphetamine seeking and self-administration and changes in CB1R/CRFR1 expression in the amygdala and nucleus accumbens in rats

Rodolfo Sanchez-Zavaleta, Lorena Alline Becerril-Melendez, Alejandra E. Ruiz-Contreras, Ana Paula Escobar-Elias, Andrea Herrera-Solis, Monica Mendez-Diaz, Miguel Perez de la Mora, Oscar E. Prospero-Garcia, Grupo Neurociencias

Summary: The study found that different patterns of drug ingestion have a different impact on the brain and the development of drug addiction. The effects of continuous low doses and intermittent high doses of ACEA on amphetamine seeking and ingestion were compared, as well as the expression of CB1R and CRFR1 in the amygdala and nucleus accumbens shell. The results showed that binge-like ingestion of drugs induced changes in the brain and increased vulnerability to drug addiction.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2023)

Article Pharmacology & Pharmacy

Evidence for the existence of facilitatory interactions between the dopamine D2 receptor and the oxytocin receptor in the amygdala of the rat. Relevance for anxiolytic actions

Juan Carlos Hernandez-Mondragon, Dexter A. Hernandez-Hernandez, Minerva Crespo-Ramirez, Oscar Prospero-Garcia, Luisa Rocha-Arrieta, Kjell Fuxe, Dasiel O. Borroto-Escuela, Miguel Perez de la Mora

Summary: Enhancing the interaction between dopamine D2 receptors (D2Rs) and oxytocin receptors (OXTRs) in the central amygdala may enhance anxiolytic effects. The coadministration of oxytocin and a D2R agonist improved the anxiolytic effects in rats. In situ proximity ligation assay and BRET2 assay provided evidence for the existence of D2R-OXTR heterocomplexes.

FRONTIERS IN PHARMACOLOGY (2023)

No Data Available